Envista's FY25 earnings are likely to exceed the consensus estimates. Click here to read why NVST stock is upgraded to Buy.

Envista Holdings Corporation’s NVST international expansion positions it for robust future growth due to deeper penetration across more markets. Additionally, it continuously assesses potential buys ...

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Stryker (SYK). But which of ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Astera Labs Inc (Symbol: ALAB), where a total of 28,091 contracts have traded so far, ...

Fintel reports that on January 20, 2026, Mizuho upgraded their outlook for Envista Holdings (NYSE:NVST) from Underperform to ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the ...

Why Envista Holdings (NVST) is on investors’ radar today Envista Holdings (NVST) has drawn fresh attention after recent ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. During Q4, the markets ...

Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Stryker (SYK). But which of these two stocks offers value investors a better bang for ...